Potassium and Inspra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Potassium (potassium) and Inspra (eplerenone). Common drug interactions include arrhythmia among females and diarrhoea among males.

The phase IV clinical study analyzes what interactions people have when they take Potassium and Inspra. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Potassium?

Potassium has active ingredients of potassium. It is often used in hypokalemia. eHealthMe is studying from 59,148 Potassium users. Check the latest studies of Potassium.

What is Inspra?

Inspra has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 3,510 Inspra users. Check the latest studies of Inspra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 03, 2026

62 people who take Potassium and Inspra together, and have interactions are studied.

Potassium and Inspra drug interactions.

What are the common drug interactions of Potassium and Inspra, by gender? *:

female:

  1. Arrhythmia (irregular heartbeat)
  2. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  3. Blood creatinine increased
  4. Blood urea increased
  5. Brain natriuretic peptide increased
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Cardiac failure
  8. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  9. Concomitant disease progression (progress in accompanying disease)
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Diarrhoea
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Tricuspid valve disease (disease of heart valve)
  4. Cough
  5. Death
  6. Dyspnoea (difficult or laboured respiration)
  7. Fatigue (feeling of tiredness)
  8. Hypotension (abnormally low blood pressure)
  9. Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
  10. Chronic kidney disease

What are the common drug interactions of Potassium and Inspra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Neuropathy peripheral (surface nerve damage)
  4. Pharyngitis (inflammation of the pharynx, causing a sore throat)

40-49:

  1. Dyspnoea (difficult or laboured respiration)
  2. Fatigue (feeling of tiredness)
  3. Dysarthria (speech disorder)
  4. Hypotension (abnormally low blood pressure)
  5. Vision blurred

50-59:

  1. Diarrhoea
  2. Dizziness
  3. Dyspnoea (difficult or laboured respiration)
  4. Dyspnoea exertional (breathlessness or shortness of breath)
  5. Eustachian tube disorder (inflammation of the middle ear, commonly affects the eustachian tube)
  6. Glomerular filtration rate decreased
  7. Gout (uric acid crystals building up in the body)
  8. Granuloma (a small area of inflammation due to tissue injury)
  9. Haematocrit decreased
  10. Haematoma (collection of blood outside the blood vessels)

60+:

  1. Diarrhoea
  2. Pain in extremity
  3. Bowen's disease (early stage of skin cancer)
  4. Cough
  5. Fall
  6. Inflammation
  7. Inguinal hernia (hernia in which a loop of intestine enters the inguinal canal; the most common type of hernia in males)
  8. Lymphopenia (an abnormally low level of lymphocytes in the blood)
  9. Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
  10. Oedema (fluid collection in tissue)

What are the existing conditions these people have? *

  1. Lambert-Eaton Syndrome (this means your immune system mistakenly targets healthy cells and tissues in the body): 13 people, 20.97%
  2. Viral Infection: 12 people, 19.35%
  3. Pneumonia: 12 people, 19.35%
  4. Cardiac Disorder: 10 people, 16.13%
  5. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 10 people, 16.13%
  6. Cardiac Failure: 8 people, 12.90%
  7. Diabetes: 7 people, 11.29%
  8. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 6 people, 9.68%
  9. High Blood Cholesterol: 6 people, 9.68%
  10. Muscle Function Loss: 6 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take Potassium and Inspra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Potassium and Inspra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Inspra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Inspra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on potassium and eplerenone (the active ingredients of Potassium and Inspra, respectively), and Potassium and Inspra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: